Literature DB >> 30004243

Mitochondria "THE" target of myocardial conditioning.

Kerstin Boengler1, Günter Lochnit2, Rainer Schulz1.   

Abstract

Several interventions, such as ischemic preconditioning, remote pre/perconditioning, or postconditioning, are known to decrease lethal myocardial ischemia-reperfusion injury. While several signal transduction pathways become activated by such maneuvers, they all have a common end point, namely, the mitochondria. These organelles represent an essential target of the cardioprotective strategies, and the preservation of mitochondrial function is central for the reduction of ischemia-reperfusion injury. In the present review, we address the role of mitochondria in the different conditioning strategies; in particular, we focus on alterations of mitochondrial function in terms of energy production, formation of reactive oxygen species, opening of the mitochondrial permeability transition pore, and mitochondrial dynamics induced by ischemia-reperfusion.

Entities:  

Keywords:  cardioprotection; conditioning; connexin43; ischemia-reperfusion; mitochondria; mitochondrial dynamics; mitochondrial permeability transition pore; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 30004243     DOI: 10.1152/ajpheart.00124.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  35 in total

Review 1.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

Review 2.  Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

3.  Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening.

Authors:  Lan Wu; Ji-Liang Tan; Zhong-Yan Chen; Gang Huang
Journal:  Basic Res Cardiol       Date:  2019-08-28       Impact factor: 17.165

4.  LGR4 silence aggravates ischemic injury by modulating mitochondrial function and oxidative stress via ERK signaling pathway in H9c2 cells.

Authors:  Tao Chen; Xiangrui Qiao; Lele Cheng; Mengping Liu; Yangyang Deng; Xiaozhen Zhuo
Journal:  J Mol Histol       Date:  2021-02-09       Impact factor: 2.611

5.  Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.

Authors:  Carolin Torregroza; Birce Yueksel; Raphael Ruske; Martin Stroethoff; Annika Raupach; André Heinen; Markus W Hollmann; Ragnar Huhn; Katharina Feige
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

6.  Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?

Authors:  Jun Chong; Andrew Fw Ho; Jonathan Yap; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Cond Med       Date:  2019-10

Review 7.  Mitochondrial ion channels as targets for cardioprotection.

Authors:  Derek J Hausenloy; Rainer Schulz; Henrique Girao; Brenda R Kwak; Diego De Stefani; Rosario Rizzuto; Paolo Bernardi; Fabio Di Lisa
Journal:  J Cell Mol Med       Date:  2020-06-03       Impact factor: 5.310

Review 8.  Protective Effects of Polyphenols against Ischemia/Reperfusion Injury.

Authors:  Martina Cebova; Olga Pechanova
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

Review 9.  Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury.

Authors:  Andrew R Kulek; Anthony Anzell; Joseph M Wider; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

10.  mPTP Proteins Regulated by Streptozotocin-Induced Diabetes Mellitus Are Effectively Involved in the Processes of Maintaining Myocardial Metabolic Adaptation.

Authors:  Natalia Andelova; Iveta Waczulikova; Ivan Talian; Matus Sykora; Miroslav Ferko
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.